The early disease screening and prevention module in our artificial intelligence system, based on deep learning technology, can quickly process massive medical data, accurately locate the lesion, analyze the condition, provide decision assistance, and improve the efficiency and accuracy of doctors.
The early disease screening and prevention module based on deep learning, annotating data with professional medical knowledge, mining and training a disease classification network, which constitutes a classification model and disease recognition model for different lesions. This module mainly includes Gesture recognition, Fundus photography analysis and Open chromatin regions analysis, can quickly detect a variety of eye diseases that threaten vision, diagnose cancer and prevent blindness, so that patients can prevent the disease from worsening in advance.
Figure 1 Gesture Recognition Pipeline (nickgillian.com)
Figure 2 Flowchart of the ensemble-based system for retinal image analysis (Renátó Besenczi, et al. 2016)
Figure 3 Overview of the SCALE framework (Xiong L, Xu K, Tian K, et al. 2019)
MedAI, a division of MedAI, provides AI-powered solutions for drug formulation development according to clients' detailed requirements. Our platform improves the efficiency and success rate of drug discovery and development with the help of advanced technologies.
Please submit a detailed description of your project. We will provide you with a customized project plan to meet your research requests. You can also send emails directly to firstname.lastname@example.org for inquiries.
Tech Trends in Artificial Intelligence What's up, what's down, what lies ahead, only found in MedAI!